The PCRP funds basic and clinical research relevant to prostate cancer that will result in substantial improvements over today's approach to the prevention, detection, diagnosis, treatment, and basic biology of the disease. Awards are designed to stimulate innovative research, address issues of morbidity and mortality, and fortify the national effort against prostate cancer.
Consumer advocates participate on all decision-making advisory panels.
Award negotiations are under way and will be completed by September 30, 2001. Phase II of the Dual Phase Awards announced in FY97 also was executed using the FY00 appropriation. Award negotiations are under way and will be completed by September 30, 2001. Since the inception of the PCRP, more than 1,950 proposals have been received. The FY97-99 appropriations resulted in 297 awards.